GlassScriptPhysician profile
Waldtraut Jedamski
NPI 1891726535
$2,589.88
in general payments reported to CMS, 2019-2025
23 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $492 · 2021: $411 · 2022: $131 · 2023: $69.28 · 2024: $292 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $964.40 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $514.48 | 2019-2025 | Belbuca, Xtampza |
| Nevro Corp. | $208.64 | 2019 | |
| Boston Scientific Corporation | $135.59 | 2024 | |
| Scilex Pharmaceuticals INC. | $133.72 | 2019-2020 | |
| Tersera Therapeutics LLC | $64.86 | 2019 | |
| Zyla Life Sciences, INC. | $62.63 | 2019 | |
| West Therapeutics Development, LLC | $57.60 | 2019 | |
| Biodelivery Sciences International, INC. | $54.25 | 2020-2021 | |
| Shionogi INC | $47.15 | 2019 | |
| Hikma Pharmaceuticals USA | $45.32 | 2022 | |
| Kaleo, INC. | $44.00 | 2019 | |
| Indivior INC. | $41.40 | 2019 | |
| Abbott Laboratories | $36.53 | 2019 | |
| Medtronic USA, INC. | $31.65 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Piramal Critical Care | $24.16 | 2019 | |
| Orexo US, INC. | $22.80 | 2019 | |
| Amgen INC. | $21.57 | 2019 | |
| Arbor Pharmaceuticals, INC. | $18.06 | 2019 | |
| Novo Nordisk INC | $17.09 | 2022 | |
| Uswm, LLC | $16.71 | 2021 | |
| Assertio Therapeutics, INC. | $14.14 | 2019 | |
| Vertos Medical, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waldtraut Jedamski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.